Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |